首页> 外文期刊>Seminars in radiation oncology >Cancer Stem Cells as a Predictive Factor in Radiotherapy
【24h】

Cancer Stem Cells as a Predictive Factor in Radiotherapy

机译:癌症干细胞是放疗的预测因素

获取原文
获取原文并翻译 | 示例
       

摘要

Cancer stem cell research is one of the most thriving and competitive areas in oncology research because it has the potential to dramatically affect clinical outcomes. Led by progress in hematology, cancer stem cell research has now provided evidence to play an important role for solid cancers as well. Because radiotherapy is only second to surgery in terms of its curative potency, it is very important for radiation oncologists to learn whether progress in cancer stem cell biology can enable them to exploit this knowledge to help cure more patients suffering from cancer. The present article gives an overview about the challenges of the cancer stem cell concept and highlights some important phenomena that are under intense investigation, such as phenotypic plasticity of stemness and impact and dynamics of microenvironmental niches. We discuss the potential and limitations of current experimental and theragnostic tools and end up with an agenda for future research as outlook for translational possibilities in the clinic.
机译:癌症干细胞研究是肿瘤学研究中最繁荣和最具竞争力的领域之一,因为它有可能极大地影响临床结果。在血液学的进步的带动下,癌症干细胞研究现已提供证据,也对实体癌也起着重要作用。因为就其疗效而言,放射疗法仅次于外科手术,因此放射肿瘤学家了解癌症干细胞生物学的进展是否可以使他们利用这一知识来帮助治愈更多的癌症患者非常重要。本文概述了癌症干细胞概念所面临的挑战,并重点介绍了一些正在深入研究的重要现象,例如干性的表型可塑性和微环境生态位的影响和动态。我们讨论了当前实验和矫正术工具的潜力和局限性,并最终提出了未来研究的议程,作为对临床翻译可能性的展望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号